2025. Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study. SKIN The Journal of Cutaneous Medicine. 9, 1 (Jan. 2025), s515. DOI:https://doi.org/10.25251/skin.9.supp.515.